City Therapeutics

City Therapeutics is a company, not a closed-end fund. We still track it - notices about it are below - but most of this site is about funds.

Is anyone targeting this fund?

Yes - 3 large investors hold stakes in this company, and 1 of them is pushing for changes.

What this means for you

ARCH Venture Fund XII, L.P. has told the regulator it may push for changes at this company. That usually means asking for a seat on the board, a sale of the company, or a change in how it is run.

Nothing is required of you now.

Large investors can also sell down and walk away. We show every notice they file, the day it is filed.

Email me if this changes

What happened, and when

  1. Oct 26, 2026

    ARCH Venture Fund XII, L.P. now owns 25.6%. It has said it may push for changes.

    Original document →
  2. Oct 26, 2026

    Viking Global Investors L.P. now owns 7%, as a passive investor.

    Original document →
  3. Oct 22, 2026

    Invus Public Equities, L.P. now owns 8.1%, as a passive investor.

    Original document →
Details: all notices, events and fund facts
Notices from large investors about City Therapeutics
DateInvestorStakeType of notice
Oct 26, 2026 ARCH Venture Fund XII, L.P. 25.6% May push for changes
Oct 26, 2026 Viking Global Investors L.P. 7% Passive investor
Oct 22, 2026 Invus Public Equities, L.P. 8.1% Passive investor

No announcements from the fund on file. Most funds announce their payout on their own website, not in a filing with the regulator, so a cut or a raise there does not show up here.

Run by
not filed yet
Fund family
not filed yet
Exchange
not listed

See this fund's page at the SEC →

Download this fund's history (CSV)

Follow this fund in a news reader (feed)

Email me when something new is filed for City Therapeutics

Free. One email when a large investor files a notice, or when the fund announces a buy-back, a vote or a closing - usually within a day. No password. Most funds announce payout changes on their own website, where we do not look.